TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
Teclison Ltd.
Teclison Ltd.
Global Coalition for Adaptive Research
American Society of Clinical Oncology
Istituto Oncologico Veneto IRCCS
University of Miami
Neonc Technologies, Inc.
Centre Leon Berard
Zhejiang University